DEFTA Partners

DEFTA Partners is a global venture capital firm founded in the 1980s, with offices in San Francisco, Tokyo, and Hong Kong. The firm specializes in early-stage investments in technology companies, particularly in the healthcare and information and communication technology (ICT) sectors. DEFTA Partners has a history of identifying, nurturing, and funding companies with innovative technologies across North America, Europe, Asia, and the Middle East.

The firm's investment strategy focuses on sectors such as biotechnology, medical devices, healthcare IT, and ICT. DEFTA Partners invests in companies developing advanced therapeutics, health ICT, and enabling technologies. The firm has a global investment approach, having invested in over 100 companies across various regions, including the United States, United Kingdom, Israel, Bangladesh, and Japan. DEFTA Partners aims to enable sustainable growth and scale its portfolio companies internationally.

DEFTA Partners has a track record of successful investments in early-stage technology companies. Notable investments include Aegle Therapeutics, Actuate Therapeutics, and QuantuMDx. The firm's founder, George Hara, has been instrumental in leading and funding numerous companies to success, including Viagene, Isis Pharmaceuticals, and Arris Pharmaceuticals. DEFTA Partners continues to focus on identifying and supporting transformative solutions that address pressing healthcare challenges and enhance patient outcomes.